Virica Biotech

$7.1Mtotal raised · 4 rounds on record
$60klatest round · Venture round · Apr 2024 · 2 yr ago
$1Mrevenue · 2023 · SEC Form D 0001140361-24-004027
1backers · Capital Angel Network

Key facts

These are the key facts about Virica Biotech on Alion as of Nov 13, 2026. Virica Biotech is headquartered in Ottawa, Canada. It was founded in 2018. It has raised $7.1M in 4 funding rounds. The latest round is Venture - Series Unknown of $60k, announced in 2024.

Headquarters
Ottawa, CanadaAlion company profile, updated Sep 29, 2026
Founded
2018Alion company profile, updated Sep 29, 2026
Employees
10+Alion company profile, an estimated range
Total raised
$7.1MSum of 4 equity rounds Alion knows
Latest round
Venture - Series Unknown · $60k · Apr 29, 2024SEC Form D filing · sec.gov
Official records

Funding and backers

Total raised
$7.1M
4 rounds on record
Latest round
$60k
Venture round · Apr 2024 · 2 yr ago
Team
11-50
employees, estimated range
Revenue
$1M
2023 · SEC Form D 0001140361-24-004027
Backers
1
Capital Angel Network
The money's age
Long since its last round
30 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 21 Launched Virica Biotech Introduces Viric.AI, an Active Learning Platform to Accelerate Biomanufacturing Optimization · TMX Newsfile Apr 8 Partnership Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada-Japan Co-Innovation Program to Advance AAV Production Enhancers · Business Wire Oct 3, 2024 Partnership Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing · Business Wire Apr 29, 2024 Raised a round Venture round $60k · SEC Form D Jan 22, 2024 Raised a round Venture round $3M · SEC Form D Apr 25, 2022 Raised a round Venture round $500k · SEC Form D Sep 27, 2021 Raised a round Venture round $3.5M · SEC Form D 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2024 $60k — SEC Form D
Venture round Jan 2024 $3M — SEC Form D
Venture round Apr 2022 $500k — SEC Form D
Venture round Sep 2021 $3.5M — SEC Form D
Founders and leadersfrom filings, registers and the company's site
Ken NewportDirector, Executive OfficerSEC Form D
Jean-Simon Dr. DialloDirector, Executive OfficerSEC Form D
Ella Korets-SmithExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Financials

Est. Annual Revenue
$500k
2023
Total raised
$7.1M
Latest round
Venture - Series Unknown
Funding rounds
4
Revenue
Estimate Low-high range Modelled from public signals, not audited accounts - read it as an order of magnitude.
Est. Annual Revenue, 2021 — 2023
YearEstimateLowHigh
2021 $500k $1 $1M
2023 $500k $1 $1M
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $60k Details
Venture - Series Unknown 2024 $3M Details
Venture - Series Unknown 2022 $500k Details
Venture - Series Unknown 2021 $3.5M Details

People

Ken Newport
Director, Executive Officer
Jean-Simon Dr. Diallo
Director, Executive Officer
Ella Korets-Smith
Executive Officer
Susan Dexter
Director
Daniella Kranjac
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
82 portfolio companies: Dealum, edgehogtech.com, FUNDERS TO MEET and 79 more

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Ottawa Canada
HQ
10-50 est. staff

How to cite this page

Alion, "Virica Biotech: key facts", as of Nov 13, 2026. https://alion.io/company/viricabiotech

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0